Anaplastic large cell lymphoma arising in bone: report of a case of the monomorphic variant with the t(2;5)(p23;q35) translocation.

Anaplastic large cell lymphoma (ALCL) represents approximately 2% of all non-Hodgkin lymphomas according to the recent Non-Hodgkin Lymphoma Classification Project. As defined in the revised European-American classification of lymphoid neoplasms (REAL), ALCL is a neoplasm of T-cell or null-cell lineage; 20% to 60% of cases are associated with the t(2;5)(p23;q35) translocation. ALCL commonly involves nodal as well as a wide variety of extranodal sites, although primary or secondary involvement of bone is rare. We describe the case of a 71-year-old man with stage IE T-cell ALCL, monomorphic variant, arising in the left anterior fifth rib and involving adjacent soft tissue without other sites of disease. The monomorphic histologic features hindered the initial recognition of this neoplasm as ALCL. However, strong uniform CD30 antigen expression and subsequent demonstration of the t(2;5)(p23;q35) translocation and anaplastic lymphoma kinase (ALK) immunoreactivity led to the correct diagnosis. We identified only 5 reported cases of T-cell and null-cell ALCL arising in bone and only 2 of these cases involved a single bone site. All 5 previously reported cases were ALCL of the classic type. We report a case of ALCL that is unique to our knowledge. This case of monomorphic ALCL was localized to bone and tumor cells contained the t(2;5)(p23;q35) translocation.

[1]  D. Dorfman,et al.  Lymphoma presenting as a solitary bone lesion. , 1999, American journal of clinical pathology.

[2]  Y. Hasegawa,et al.  Anaplastic large-cell lymphoma of null-cell type with multiple bone involvement , 1998, Annals of Hematology.

[3]  A. Hagemeijer,et al.  The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. , 1998, Blood.

[4]  S. Pileri,et al.  ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. , 1998, The American journal of pathology.

[5]  J. Chan,et al.  Anaplastic Large Cell Lymphoma: Redefining Its Morphologic Spectrum and Importance of Recognition of the ALK‐Positive Subset , 1998, Advances in anatomic pathology.

[6]  L. Medeiros,et al.  Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[7]  S. Pileri,et al.  ALK-positive lymphoma: a single disease with a broad spectrum of morphology. , 1998, Blood.

[8]  M. Seto,et al.  Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression. , 1997, The American journal of surgical pathology.

[9]  E. Campo,et al.  The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. , 1997, The American journal of pathology.

[10]  R. Alsabeh,et al.  Transformation of follicular lymphoma into CD30-large cell lymphoma with anaplastic cytologic features. , 1997, The American journal of surgical pathology.

[11]  K. Pulford,et al.  Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. , 1997, Blood.

[12]  S. Pileri,et al.  CD30+ anaplastic large‐cell lymphoma, null type, with signet‐ring appearance , 1997, Histopathology.

[13]  C. D. Wu,et al.  Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases. , 1996, American journal of clinical pathology.

[14]  S. Mori,et al.  Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. , 1995, Leukemia.

[15]  J. Downing,et al.  Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. , 1995, Blood.

[16]  M. Borowitz,et al.  Neutrophil‐Rich, Ki‐1-Positive Anaplastic Large‐Cell Malignant Lymphoma , 1995, The American journal of surgical pathology.

[17]  H. Satoh,et al.  Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. , 1994, Blood.

[18]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[19]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.

[20]  J. Whitlock,et al.  A Small‐Cell‐Predominant Variant of Primary Ki‐1 (CD30)+ T‐Cell Lymphoma , 1993, The American journal of surgical pathology.

[21]  A. Komiyama,et al.  Ki-1 positive large cell anaplastic lymphoma: multiple bone lytic lesions and interleukin-6. , 1992, Leukemia & lymphoma.

[22]  V. Sin,et al.  Anaplastic large cell Ki‐1 lymphoma of bone , 1991, Cancer.

[23]  C. Fletcher,et al.  Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. , 1990, The American journal of surgical pathology.

[24]  A. Chott,et al.  Ki‐1‐Positive Large Cell Lymphoma: A Clinicopathologic Study of 41 Cases , 1990, The American journal of surgical pathology.

[25]  S. Pileri,et al.  Lymphohistiocytic T‐cell lymphoma (anaplastic large cell lymphoma CD30+/Ki‐1 + with a high content of reactive histiocytes) , 1990, Histopathology.

[26]  H. Takita,et al.  [Childhood Ki-1 lymphoma complicated with multiple bone destruction]. , 1989, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[27]  J. Chan,et al.  Anaplastic large cell Ki‐1 lymphoma. Delineation of two morphological types , 1989, Histopathology.

[28]  K. Lennert,et al.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. , 1985, Blood.

[29]  M. Kadin,et al.  The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. , 1999, American journal of clinical pathology.

[30]  A. Bernheim,et al.  High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. , 1996, Blood.

[31]  T. Greiner,et al.  Analysis of T cell receptor-gamma gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Correlation with tumor-specific sequences. , 1995, The American journal of pathology.

[32]  S. Perkins,et al.  Anaplastic large-cell lymphoma presenting primarily in bone in a patient with AIDS. , 1994, Hematologic pathology.